National Institutes of Health to Grant Exclusive License for Veterinary Vaccine and Therapeutic Uses of Bartonella Henselae Organisms

Summary

The National Institutes of Health is considering granting a worldwide, limited field of use, exclusive license to Paravax, Inc. for the use of patents and patent applications related to diagnosing cat scratch disease and bacillary angiomatosis caused by Bartonella henselae, a bacterium previously known as Rochalimaea henselae.